Memphasys Ltd (AU:MEM) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Memphasys Limited has appointed Lindley Edwards as the new Non-Executive Chairperson, succeeding Robert Cooke, as the company nears the completion of its clinical trial for the Felix™ System. Edwards brings over 30 years of experience in financial services and corporate governance, aiming to steer Memphasys towards global commercialisation of its sperm separation technology and RoXsta™ System. These advancements are set to strengthen Memphasys’ position in the fertility and biotechnology markets.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.
